Weekly Spotlight - 14.11.24

Community

We want to hear your story!

Fill in the form to share your experiences and any challenges you’ve faced living with your condition, for a chance to be featured in one of our weekly newsletters!

In the News

Discovering Key Genes in Pompe Disease Through Machine Learning

This study explores immune cell infiltration in infantile-onset Pompe disease using bioinformatics and machine learning. Key genes GPNMB, CALML6, and TRIM7 were identified, linked to immune responses. Findings suggest potential biomarkers and therapeutic targets, offering hope for improved diagnosis and treatment, though further research is needed for validation.

Feeding Therapy Offers Hope for Children with Pompe Disease

Keara Engle explores feeding therapy for her son, Cayden, who has Pompe disease and uses a G-tube. She hopes therapy will help him eat orally. Cayden's new speech therapist suggested a nearby facility offering feeding therapy, and Keara plans to schedule an appointment soon.

Pompe Disease Diagnosed in Over 700 Patients Using Two-Step Process

A two-step process involving biochemical and genetic testing has successfully diagnosed over 700 individuals with Pompe disease from 57 countries. This approach, which screened over 30,000 suspected cases, highlights the importance of early diagnosis for effective treatment, offering hope and support to affected families worldwide.

Avalglucosidase Alfa Home Infusion: Safe and Effective for Pompe Patients

Avalglucosidase alfa home infusions for Pompe disease patients were safe and effective in clinical trials. Seventeen participants received 419 infusions at home, with adverse events comparable to clinic settings. This approach reduces treatment burden, enhancing quality of life for patients and caregivers.